Clinical Trial: Study of High-risk Prostate Cancer About Predicting Lymph Node Metastasis by Artificial Intelligence Multi-omics Analysis

U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07112599) titled 'Study of High-risk Prostate Cancer About Predicting Lymph Node Metastasis by Artificial Intelligence Multi-omics Analysis' on July 28.

Brief Summary: The pathological-omics and imaging-omics in this study were combined to construct an artificial intelligence (AI) model that can predict whether high-risk prostate cancer patients will have lymph node metastasis. The model determines whether the patient has lymph node metastasis based on the follow-up results (MRI) before radical resection of the prostate and the pathological section image information of the case combined with clinical data. This study is a multicenter, prospective clin...